Cancer Immunotherapeutics Center Protocol: 19-052Title: A Phase 1/2 First-in-human Study of the Safety and Efficacy of IMC-C103C as a Single Agent and in Combination with Atezolizumab in HLA-A*0201-positive Patients Protocol: 19-063Title: Phase 1/1b Study of the Safety of TTX-030 as a Single Agent and in Combination with Pembrolizumab or Chemotherapy in Patients with Lymphoma or […]

Immunotherapy may work better in stomach cancer when combined with chemotherapy Washington [US], November 6 (ANI): Immunotherapy for stomach cancer may work better if the therapy is delivered earlier in the course of the disease and in combination with standard chemotherapy, a new study from researchers at Columbia University Vagelos College of Physicians and Surgeons […]

How to Live With the Cancer You May Never Get The waiting game is a different experience for every woman with a BRCA gene mutation Jessica Furseth 1 hour ago·9 min read Illustration: Cha Pornea Three years ago, Mary Margaret, 31, from Vermont, learned that her BRCA gene has a mutation that may well one […]